Inside the research

Quest Diagnostics Incorporated

DGX Research profile · latest available data

Price overview

$236.32

▼ -0.27 (-0.1%)

52w hi$247.45
52w lo$171.25
Vol741.70K
As of25 Sep 2026

The Verdict

Buy

Our score +0.55

Short+0.48
Medium+0.68
Long+0.45

computed 2026-09-27

Key fundamentals

Quest Diagnostics Incorporated

Healthcare · Diagnostics & Research

Market cap$26.08B
Enterprise value$32.24B
Trailing P/E25.09x
Forward P/E19.60x
EV / EBITDA14.23x
P / S (ttm)2.26x
Profit margin9.2%
Return on equity14.6%
Revenue growth+10.2%
Earnings growth+15.0%
Debt / equity81.07

Layer Breakdown

LayerRawContribution
Fundamental+0.25
Sector+0.08
Technical+0.39
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

United States · www.questdiagnostics.com

Risk Metrics

Beta vs SPX0.15
Corr SPX0.10
Annual vol23.5%
Annual ret+24.5%
Sharpe1.04
Max DD-11.9%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$223.25
High / Low$245.00 / $184.00
Median$225.00
Analysts16
Strong Buy2
Buy7
Hold9
Sell0
Strong Sell0

Recent rating actions

2026-04-22UBS→ Neutral
2026-04-22Truist Securities→ Hold
2026-04-22Barclays→ Overweight
2026-04-22Baird→ Neutral
2026-04-08Evercore ISI Group→ In-Line
2026-02-12Mizuho→ Outperform

Material Events

DateEvent8-K
2026-07-23Earnings Release, Exhibitsread
2026-05-21Shareholder Voteread
2026-05-08Material Agreement, Exhibitsread
2026-05-01Other Material Event, Exhibitsread
2026-04-21Earnings Release, Exhibitsread
2026-03-12Officer / Director Change, Reg FD Disclosure…read
2026-02-10Earnings Release, Other Material Event…read
2026-01-12Earnings Release, Reg FD Disclosure…read
2025-10-21Earnings Release, Exhibitsread
2025-07-22Earnings Release, Exhibitsread
2025-05-22Shareholder Voteread
2025-04-22Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-07-28DELANEY MARK ESVP & Chief Commercial OfSell1.60K$376.29K
2026-07-22KUPPUSAMY KARTHIKSVP, Clinical SolutionsL37$7.65K
2026-07-22CARTER ROBERT BL11$2.27K
2026-07-22Gregg Vicky BGrant72$14.89K
2026-07-22Plewman PatrickSVP for Diagnostic ServicL46$9.51K
2026-07-22MAIN TIMOTHY LL21$4.34K
2026-07-22SAMAD SAMExecutive Vice President Grant102$21.09K
2026-07-22Lassiter Wright IIIL6$1.24K
2026-07-22DELANEY MARK ESVP & Chief Commercial OfL34$7.03K

Flow & Concentration

Insider 180d net-$376.29K
Insider buys / sells0 / 1
Insider biasNeutral
13F holders0
Top-5 share0.0%
HHI0 (—)

Dividends

Yield (TTM)1.04%
$ / share (TTM)$2.46
5y CAGR+7.3%

Annual dividend per share

2021$2.42
2022$2.60
2023$2.79
2024$2.96
2025$3.15
2026$1.66

SEC Filings

DateFormDoc
2026-07-294view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-274view
2026-07-2310-Qview
2026-07-238-Kview
2026-07-024view
2026-06-1811-Kview
2026-06-084view
2026-06-024view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$11.04B+2.7%
Gross profit$552.00M-3.6%
Operating income$1.26B+0.2%
Net income$854.00M+1.0%
Cash from ops$1.33B+2.3%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$236.37$238.25$235.48$236.32741.70K
Sep 24$234.08$237.29$233.55$236.59926.90K
Sep 23$235.12$238.62$231.92$233.001.13M
Sep 22$228.59$237.29$227.24$234.762.72M
Sep 21$247.13$248.84$243.93$244.88907.60K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →